New to Podcasts?
Abaloparatide for osteoporosis, cost-effectiveness of PCSK9 inhibitors, review of aortic dissection, and more

JAMA Editor’s Summary

Abaloparatide for osteoporosis, cost-effectiveness of PCSK9 inhibitors, review of aortic dissection, and more

Abaloparatide for osteoporosis, cost-effectiveness of PCSK9 inhibitors, review of aortic dissection, and more

Editor’s Audio Summary by Edward Livingston, MD, Deputy Editor, JAMA, the Journal of the American Medical Association, for the August 16, 2016 issue

The Latest Health Podcasts. Delivered to Your Inbox.

Proudly supported by:

cover Welcome to the Health Podcast Network!
00:00
00:00
volume-low